Can serum glial fibrillary acidic protein (GFAP) solve the longstanding problem of diagnosis and monitoring progressive multiple sclerosis

被引：2

作者：

Groen, Kira ^{[1
,2
]}

Lechner-Scott, Jeannette ^{[1
,2
]}

Pohl, Daniela ^{[3
]}

Levy, Michael ^{[4
]}

Giovannoni, Gavin ^{[5
]}

Hawkes, Chris ^{[6
]}

机构：

[1] Univ Newcastle, Hunter Med Researc Inst, Newcastle, NSW, Australia

[2] Hunter New England Area Hlth, Newcastle, NSW, Australia

[3] Univ Ottawa, Ottawa, ON, Canada

[4] Harvard Univ, Cambridge, MA 02138 USA

[5] Queen Mary Univ London, Barts & London Sch Med & Dent, Blizard Inst, Dept Neurol, London, England

[6] Queen Mary Univ London, Dept Neurol, Neurosci Ctr, London, England

来源：

MULTIPLE SCLEROSIS AND RELATED DISORDERS | 2021年 / 50卷

关键词：

WHITE-MATTER LESIONS; NEUROMYELITIS-OPTICA; SPECTRUM;

D O I：

10.1016/j.msard.2021.102931

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

引用

页数：2

共 28 条

[11] Comparing Glial Fibrillary Acidic Protein (GFAP) in Serum and Plasma Following Mild Traumatic Brain Injury in Older Adults [J].

Huebschmann, Nathan A. ;

Luoto, Teemu M. ;

Karr, Justin E. ;

Berghem, Ksenia ;

Blennow, Kaj ;

Zetterberg, Henrik ;

Ashton, Nicholas J. ;

Simren, Joel ;

Posti, Jussi P. ;

Gill, Jessica M. ;

Iverson, Grant L. .

FRONTIERS IN NEUROLOGY, 2020, 11

[12] A Score Based on NfL and Glial Markers May Differentiate Between Relapsing-Remitting and Progressive MS Course [J].

Huss, Andre ;

Otto, Markus ;

Senel, Makbule ;

Ludolph, Albert C. ;

Abdelhak, Ahmed ;

Tumani, Hayrettin .

FRONTIERS IN NEUROLOGY, 2020, 11

[13] Multiple sclerosis with and without CSF bands: Clinically indistinguishable but immunogenetically distinct [J].

Imrell, Kerstin ;

Landtblom, Anne-Marie ;

Hillert, Jan ;

Masterman, Thomas .

NEUROLOGY, 2006, 67 (06) :1062-1064

[14] Evaluation of MS related central fatigue using MR neuroimaging methods: Scoping review [J].

Jameen, A. R. M. ;

Ribbons, Karen ;

Lechner-Scott, Jeannette ;

Ramadan, Saadallah .

JOURNAL OF THE NEUROLOGICAL SCIENCES, 2019, 400 :52-71

[15] Aquaporin-4 Antibodies (NMO-IgG) as a Serological Marker of Neuromyelitis Optica: A Critical Review of the Literature [J].

Jarius, Sven ;

Wildemann, Brigitte .

BRAIN PATHOLOGY, 2013, 23 (06) :661-683

[16] Cerebrospinal fluid biomarkers of white matter lesions - cross-sectional results from the LADIS study [J].

Jonsson, M. ;

Zetterberg, H. ;

van Straaten, E. ;

Lind, K. ;

Syversen, S. ;

Edman, A. ;

Blennow, K. ;

Rosengren, L. ;

Pantoni, L. ;

Inzitari, D. ;

Wallin, A. .

EUROPEAN JOURNAL OF NEUROLOGY, 2010, 17 (03) :377-382

[17] Neurofilaments as biomarkers in neurological disorders [J].

Khalil, Michael ;

Teunissen, Charlotte E. ;

Otto, Markus ;

Piehl, Fredrik ;

Sormani, Maria Pia ;

Gattringer, Thomas ;

Barro, Christian ;

Kappos, Ludwig ;

Comabella, Manuel ;

Fazekas, Franz ;

Petzold, Axel ;

Blennow, Kaj ;

Zetterberg, Henrik ;

Kuhle, Jens .

NATURE REVIEWS NEUROLOGY, 2018, 14 (10) :577-589

[18] Blood neurofilament light chain as a biomarker of MS disease activity and treatment response [J].

Kuhle, Jens ;

Kropshofer, Harald ;

Haering, Dieter A. ;

Kundu, Uma ;

Meinert, Rolf ;

Barro, Christian ;

Dahlke, Frank ;

Tomic, Davorka ;

Leppert, David ;

Kappos, Ludwig .

NEUROLOGY, 2019, 92 (10) :E1007-E1015

[19] Menopause and multiple sclerosis: Influence on prognosis and role of disease-modifying drugs and hormonal replacement therapy [J].

Midaglia, Luciana ;

Otero, Susana ;

Baro, Francesc ;

Montalban, Xavier ;

Tintore, Mar .

MULTIPLE SCLEROSIS JOURNAL, 2022, 28 (02) :173-182

[20] GFAP in health and disease [J].

Middeldorp, J. ;

Hol, E. M. .

PROGRESS IN NEUROBIOLOGY, 2011, 93 (03) :421-443

← 1 2 3 →